Skip to main content
SpringerLink
Log in

Critical Limb Ischemia

  • Chapter
  • First Online:
Essentials of Vascular Surgery for the General Surgeon

Abstract

Critical limb ischemia (CLI) represents the most severe manifestation of peripheral arterial disease and is defined as the presence of chronic ischemic rest pain, ischemic ulcers, or gangrene attributable to objectively proven arterial occlusive disease. Primary treatment goals include relief of ischemic rest pain, healing of ischemic ulcers, limb salvage, and improvement in quality of life.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45(Suppl S):S5–67.

    Article  PubMed  Google Scholar 

  2. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006;113(11):e463–654.

    Article  PubMed  Google Scholar 

  3. Varu VN, Hogg ME, Kibbe MR. Critical limb ischemia. J Vasc Surg. 2010;51(1):230–41.

    Article  PubMed  Google Scholar 

  4. Suggested standards for reports dealing with lower extremity ischemia. Prepared by the Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery/North American Chapter, International Society for Cardiovascular Surgery. J Vasc Surg. 1986;4(1):80–94.

    Google Scholar 

  5. DeWeese JA, Leather R, Porter J. Practice guidelines: lower extremity revascularization. J Vasc Surg. 1993;18(2):280–94.

    Article  PubMed  CAS  Google Scholar 

  6. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286(11):1317–24.

    Article  PubMed  CAS  Google Scholar 

  7. O’Hare AM, Katz R, Shlipak MG, Cushman M, Newman AB. Mortality and cardiovascular risk across the ankle-arm index spectrum: results from the Cardiovascular Health Study. Circulation. 2006;113(3):388–93.

    Article  PubMed  Google Scholar 

  8. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999–2000. Circulation. 2004;110(6):738–43.

    Article  PubMed  Google Scholar 

  9. Smith Jr SC, Milani RV, Arnett DK, et al. Atherosclerotic vascular disease conference: writing group II: risk factors. Circulation. 2004;109(21):2613–6.

    Article  PubMed  Google Scholar 

  10. Criqui MH, Fronek A, Klauber MR, Barrett-Connor E, Gabriel S. The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: results from noninvasive testing in a defined population. Circulation. 1985;71(3):516–22.

    Article  PubMed  CAS  Google Scholar 

  11. Hankey GJ, Norman PE, Eikelboom JW. Medical treatment of peripheral arterial disease. JAMA. 2006;295(5):547–53.

    Article  PubMed  CAS  Google Scholar 

  12. Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol. 1991;20(2):384–92.

    Article  PubMed  CAS  Google Scholar 

  13. Mehler PS, Coll JR, Estacio R, Esler A, Schrier RW, Hiatt WR. Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes. Circulation. 2003;107(5):753–6.

    Article  PubMed  Google Scholar 

  14. Dormandy JA, Murray GD. The fate of the claudicant – a prospective study of 1969 claudicants. Eur J Vasc Surg. 1991;5(2):131–3.

    Article  PubMed  CAS  Google Scholar 

  15. Koelemay MJ, den Hartog D, Prins MH, Kromhout JG, Legemate DA, Jacobs MJ. Diagnosis of arterial disease of the lower extremities with duplex ultrasonography. Br J Surg. 1996;83(3):404–9.

    Article  PubMed  CAS  Google Scholar 

  16. Eiberg JP, Gronvall Rasmussen JB, Hansen MA, Schroeder TV. Duplex ultrasound scanning of peripheral arterial disease of the lower limb. Eur J Vasc Endovasc Surg. 2010;40(4):507–12.

    Article  PubMed  CAS  Google Scholar 

  17. Sensier Y, Hartshorne T, Thrush A, Nydahl S, Bolia A, London NJ. A prospective comparison of lower limb colour-coded Duplex scanning with arteriography. Eur J Vasc Endovasc Surg. 1996;11(2):170–5.

    Article  PubMed  CAS  Google Scholar 

  18. Larch E, Minar E, Ahmadi R, et al. Value of color duplex sonography for evaluation of tibioperoneal arteries in patients with femoropopliteal obstruction: a prospective comparison with anterograde intraarterial digital subtraction angiography. J Vasc Surg. 1997;25(4):629–36.

    Article  PubMed  CAS  Google Scholar 

  19. Katsamouris AN, Giannoukas AD, Tsetis D, Kostas T, Petinarakis I, Gourtsoyiannis N. Can ultrasound replace arteriography in the management of chronic arterial occlusive disease of the lower limb? Eur J Vasc Endovasc Surg. 2001;21(2):155–9.

    Article  PubMed  CAS  Google Scholar 

  20. Heijenbrok-Kal MH, Kock MC, Hunink MG. Lower extremity arterial disease: multidetector CT angiography meta-analysis. Radiology. 2007;245(2):433–9.

    Article  PubMed  Google Scholar 

  21. Met R, Bipat S, Legemate DA, Reekers JA, Koelemay MJ. Diagnostic performance of computed tomography angiography in peripheral arterial disease: a systematic review and meta-analysis. JAMA. 2009;301(4):415–24.

    Article  PubMed  CAS  Google Scholar 

  22. Fleischmann D, Hallett RL, Rubin GD. CT angiography of peripheral arterial disease. J Vasc Interv Radiol. 2006;17(1):3–26.

    Article  PubMed  Google Scholar 

  23. Swan JS, Carroll TJ, Kennell TW, et al. Time-resolved three-dimensional contrast-enhanced MR angiography of the peripheral vessels. Radiology. 2002;225(1):43–52.

    Article  PubMed  Google Scholar 

  24. Meaney JF, Ridgway JP, Chakraverty S, et al. Stepping-table gadolinium-enhanced digital subtraction MR angiography of the aorta and lower extremity arteries: preliminary experience. Radiology. 1999;211(1):59–67.

    Article  PubMed  CAS  Google Scholar 

  25. Willmann JK, Wildermuth S, Pfammatter T, et al. Aortoiliac and renal arteries: prospective intraindividual comparison of contrast-enhanced three-dimensional MR angiography and multi-detector row CT angiography. Radiology. 2003;226(3):798–811.

    Article  PubMed  Google Scholar 

  26. Owen AR, Robertson IR, Annamalai G, et al. Critical lower-limb ischemia: the diagnostic performance of dual-phase injection MR angiography (including high-resolution distal imaging) compared with digital subtraction angiography. J Vasc Interv Radiol. 2009;20(2):165–72.

    Article  PubMed  Google Scholar 

  27. Krous HF, Breisch E, Chadwick AE, Pinckney L, Malicki DM, Benador N. Nephrogenic systemic fibrosis with multiorgan involvement in a teenage male after lymphoma, Ewing’s sarcoma, end-stage renal disease, and hemodialysis. Pediatr Dev Pathol. 2007;10(5):395–402.

    Article  PubMed  Google Scholar 

  28. Kucher C, Steere J, Elenitsas R, Siegel DL, Xu X. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis with diaphragmatic involvement in a patient with respiratory failure. J Am Acad Dermatol. 2006;54(2 Suppl):S31–4.

    Article  PubMed  Google Scholar 

  29. Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326(6):381–6.

    Article  PubMed  CAS  Google Scholar 

  30. Wong T, Detsky AS. Preoperative cardiac risk assessment for patients having peripheral vascular surgery. Ann Intern Med. 1992;116(9):743–53.

    Article  PubMed  CAS  Google Scholar 

  31. Kelly R, Staines A, MacWalter R, Stonebridge P, Tunstall-Pedoe H, Struthers AD. The prevalence of treatable left ventricular systolic dysfunction in patients who present with noncardiac vascular episodes: a case-control study. J Am Coll Cardiol. 2002;39(2):219–24.

    Article  PubMed  Google Scholar 

  32. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol. 2007;50(17):1707–32.

    Article  PubMed  Google Scholar 

  33. Rooke TW, Hirsch AT, Misra S, et al. ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine, and Society for Vascular Surgery. Catheter Cardiovasc Interv. 2011;79(4):501–31.

    PubMed  Google Scholar 

  34. Long-term mortality and its predictors in patients with critical leg ischaemia. The I.C.A.I. Group (Gruppo di Studio dell’Ischemia Cronica Critica degli Arti Inferiori). The Study Group of Critical Chronic Ischemia of the Lower Extremities. Eur J Vasc Endovasc Surg. 1997;14(2):91–5.

    Google Scholar 

  35. Adam DJ, Beard JD, Cleveland T, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366(9501):1925–34.

    Article  PubMed  CAS  Google Scholar 

  36. Bradbury AW, Adam DJ, Bell J, et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. J Vasc Surg. 2010;51(5 Suppl):5S–17.

    Article  PubMed  Google Scholar 

  37. Taylor SM, Kalbaugh CA, Gray BH, et al. The LEGS score: a proposed grading system to direct treatment of chronic lower extremity ischemia. Ann Surg. 2003;237(6):812–8; discussion 818–9.

    PubMed  PubMed Central  Google Scholar 

  38. Couch NP, Clowes AW, Whittemore AD, Lombara JA, Henderson BA, Mannick JA. The iliac-origin arterial graft: a useful alternative for iliac occlusive disease. Surgery. 1985;97(1):83–7.

    PubMed  CAS  Google Scholar 

  39. Brewster DC, Darling RC. Optimal methods of aortoiliac reconstruction. Surgery. 1978;84(6):739–48.

    PubMed  CAS  Google Scholar 

  40. Littooy FN, Steffan G, Steinam S, Saletta C, Greisler HP. An 11-year experience with aortofemoral bypass grafting. Cardiovasc Surg. 1993;1(3):232–8.

    PubMed  CAS  Google Scholar 

  41. Mingoli A, Sapienza P, Feldhaus RJ, di Marzo L, Burchi C, Cavallaro A. Aortoiliofemoral bypass graft in young adults: long-term results in a series of sixty-eight patients. Surgery. 1997;121(6):646–53.

    Article  PubMed  CAS  Google Scholar 

  42. Tiek J, Remy P, Sabbe T, et al. Laparoscopic versus open approach for aortobifemoral bypass for severe aorto-iliac occlusive disease – a multicentre randomised controlled trial. Eur J Vasc Endovasc Surg. 2012;43(6):711–5.

    Article  PubMed  CAS  Google Scholar 

  43. Connolly JE, Price T. Aortoiliac endarterectomy: a lost art? Ann Vasc Surg. 2006;20(1):56–62.

    Article  PubMed  Google Scholar 

  44. Carsten 3rd CG, Kalbaugh CA, Langan 3rd EM, et al. Contemporary outcomes of iliofemoral bypass grafting for unilateral aortoiliac occlusive disease: a 10-year experience. Am Surg. 2008;74(6):555–9; discussion 559–60.

    PubMed  Google Scholar 

  45. Schneider JR, McDaniel MD, Walsh DB, Zwolak RM, Cronenwett JL. Axillofemoral bypass: outcome and hemodynamic results in high-risk patients. J Vasc Surg. 1992;15(6):952–62; discussion 962–63.

    Article  PubMed  CAS  Google Scholar 

  46. Chiu KW, Davies RS, Nightingale PG, Bradbury AW, Adam DJ. Review of direct anatomical open surgical management of atherosclerotic aorto-iliac occlusive disease. Eur J Vasc Endovasc Surg. 2010;39(4):460–71.

    Article  PubMed  CAS  Google Scholar 

  47. Dattilo PB, Casserly IP. Critical limb ischemia: endovascular strategies for limb salvage. Prog Cardiovasc Dis. 2011;54(1):47–60.

    Article  PubMed  Google Scholar 

  48. Jongkind V, Akkersdijk GJ, Yeung KK, Wisselink W. A systematic review of endovascular treatment of extensive aortoiliac occlusive disease. J Vasc Surg. 2010;52(5):1376–83.

    Article  PubMed  Google Scholar 

  49. Kashyap VS, Pavkov ML, Bena JF, et al. The management of severe aortoiliac occlusive disease: endovascular therapy rivals open reconstruction. J Vasc Surg. 2008;48(6):1451–7. 1457.e1451–3.

    Article  PubMed  Google Scholar 

  50. Klinkert P, Schepers A, Burger DH, van Bockel JH, Breslau PJ. Vein versus polytetrafluoroethylene in above-knee femoropopliteal bypass grafting: five-year results of a randomized controlled trial. J Vasc Surg. 2003;37(1):149–55.

    Article  PubMed  Google Scholar 

  51. Klinkert P, Post PN, Breslau PJ, van Bockel JH. Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature. Eur J Vasc Endovasc Surg. 2004;27(4):357–62.

    Article  PubMed  CAS  Google Scholar 

  52. Faglia E, Dalla Paola L, Clerici G, et al. Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003. Eur J Vasc Endovasc Surg. 2005;29(6):620–7.

    Article  PubMed  CAS  Google Scholar 

  53. Albers M, Romiti M, Brochado-Neto FC, De Luccia N, Pereira CA. Meta-analysis of popliteal-to-distal vein bypass grafts for critical ischemia. J Vasc Surg. 2006;43(3):498–503.

    Article  PubMed  Google Scholar 

  54. Okazaki J, Guntani A, Homma K, et al. Mid-term clinical outcome of critical limb ischemia after infrapopliteal bypass surgery. Fukuoka Igaku Zasshi. 2011;102(2):31–9.

    PubMed  Google Scholar 

  55. Quinones-Baldrich WJ, Prego AA, Ucelay-Gomez R, et al. Long-term results of infrainguinal revascularization with polytetrafluoroethylene: a ten-year experience. J Vasc Surg. 1992;16(2):209–17.

    Article  PubMed  CAS  Google Scholar 

  56. Fichelle JM, Marzelle J, Colacchio G, Gigou F, Cormier F, Cormier JM. Infrapopliteal polytetrafluoroethylene and composite bypass: factors influencing patency. Ann Vasc Surg. 1995;9(2):187–96.

    Article  PubMed  CAS  Google Scholar 

  57. Lancaster RT, Conrad MF, Patel VI, Cambria RP, LaMuraglia GM. Predictors of early graft failure after infrainguinal bypass surgery: a risk-adjusted analysis from the NSQIP. Eur J Vasc Endovasc Surg. 2012;43(5):549–55.

    Article  PubMed  CAS  Google Scholar 

  58. LaMuraglia GM, Conrad MF, Chung T, Hutter M, Watkins MT, Cambria RP. Significant perioperative morbidity accompanies contemporary infrainguinal bypass surgery: an NSQIP report. J Vasc Surg. 2009;50(2):299–304, 304.e291–4.

    Article  PubMed  Google Scholar 

  59. Conrad MF, Kang J, Cambria RP, et al. Infrapopliteal balloon angioplasty for the treatment of chronic occlusive disease. J Vasc Surg. 2009;50(4):799–805 e4.

    Article  PubMed  Google Scholar 

  60. Bolia A, Brennan J, Bell PR. Recanalisation of femoro-popliteal occlusions: improving success rate by subintimal recanalisation. Clin Radiol. 1989;40(3):325.

    Article  PubMed  CAS  Google Scholar 

  61. Nadal LL, Cynamon J, Lipsitz EC, Bolia A. Subintimal angioplasty for chronic arterial occlusions. Tech Vasc Interv Radiol. 2004;7(1):16–22.

    Article  PubMed  Google Scholar 

  62. Yan BP, Moran D, Hynes BG, Kiernan TJ, Yu CM. Advances in endovascular treatment of critical limb ischemia. Circ J. 2011;75(4):756–65.

    Article  PubMed  Google Scholar 

  63. Sidhu R, Pigott J, Pigott M, Comerota A. Subintimal angioplasty for advanced lower extremity ischemia due to TASC II C and D lesions of the superficial femoral artery. Vasc Endovascular Surg. 2010;44(8):633–7.

    Article  PubMed  Google Scholar 

  64. Tartari S, Zattoni L, Rizzati R, et al. Subintimal angioplasty as the first-choice revascularization technique for infrainguinal arterial occlusions in patients with critical limb ischemia. Ann Vasc Surg. 2007;21(6):819–28.

    Article  PubMed  CAS  Google Scholar 

  65. Clair DG. Critical limb ischemia: will atherectomy and laser-directed therapy be the answer? Semin Vasc Surg. 2006;19(2):96–101.

    Article  PubMed  Google Scholar 

  66. Collaborative overview of randomised trials of antiplatelet therapy – II: maintenance of vascular graft or arterial patency by antiplatelet therapy. Antiplatelet Trialists’ Collaboration. BMJ. 1994;308(6922):159–68.

    Google Scholar 

  67. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324(7329):71–86.

    Google Scholar 

  68. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet. 1996;348(9038):1329–39.

    Google Scholar 

  69. Bhatt DL, Fox KA, Hacke W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006;354(16):1706–17.

    Article  PubMed  CAS  Google Scholar 

  70. Anand S, Yusuf S, Xie C, et al. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease. N Engl J Med. 2007;357(3):217–27.

    Article  PubMed  CAS  Google Scholar 

  71. Alonso-Coello P, Bellmunt S, McGorrian C, et al. Antithrombotic therapy in peripheral artery disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e669S–90.

    PubMed  CAS  PubMed Central  Google Scholar 

  72. Jorneskog G, Brismar K, Fagrell B. Low molecular weight heparin seems to improve local capillary circulation and healing of chronic foot ulcers in diabetic patients. Vasa. 1993;22(2):137–42.

    PubMed  CAS  Google Scholar 

  73. Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral Anticoagulants or Aspirin Study): a randomised trial. Lancet. 2000;355(9201):346–51.

    Google Scholar 

  74. Johnson WC, Williford WO. Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass procedures: a prospective randomized study. J Vasc Surg. 2002;35(3):413–21.

    Article  PubMed  Google Scholar 

  75. Thompson PD, Zimet R, Forbes WP, Zhang P. Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication. Am J Cardiol. 2002;90(12):1314–9.

    Article  PubMed  CAS  Google Scholar 

  76. Enoch S, Grey JE, Harding KG. ABC of wound healing. Non-surgical and drug treatments. BMJ. 2006;332(7546):900–3.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Eginton MT, Brown KR, Seabrook GR, Towne JB, Cambria RA. A prospective randomized evaluation of negative-pressure wound dressings for diabetic foot wounds. Ann Vasc Surg. 2003;17(6):645–9.

    Article  PubMed  Google Scholar 

  78. Kranke P, Bennett M, Roeckl-Wiedmann I, Debus S. Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev. 2004;(2):CD004123.

    Google Scholar 

  79. Cavanagh PR, Bus SA. Off-loading the diabetic foot for ulcer prevention and healing. Plast Reconstr Surg. 2011;127 Suppl 1:248S–56.

    Article  PubMed  Google Scholar 

  80. Frykberg RG, Lavery LA, Pham H, Harvey C, Harkless L, Veves A. Role of neuropathy and high foot pressures in diabetic foot ulceration. Diabetes Care. 1998;21(10):1714–9.

    Article  PubMed  CAS  Google Scholar 

  81. Pham H, Armstrong DG, Harvey C, Harkless LB, Giurini JM, Veves A. Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial. Diabetes Care. 2000;23(5):606–11.

    Article  PubMed  CAS  Google Scholar 

  82. Sultan S, Esan O, Fahy A. Nonoperative active management of critical limb ischemia: initial experience using a sequential compression biomechanical device for limb salvage. Vascular. 2008;16(3):130–9.

    Article  PubMed  Google Scholar 

  83. Kavros SJ, Delis KT, Turner NS, et al. Improving limb salvage in critical ischemia with intermittent pneumatic compression: a controlled study with 18-month follow-up. J Vasc Surg. 2008;47(3):543–9.

    Article  PubMed  Google Scholar 

  84. Patel GK. The role of nutrition in the management of lower extremity wounds. Int J Low Extrem Wounds. 2005;4(1):12–22.

    Article  PubMed  Google Scholar 

  85. Pedersen NW, Pedersen D. Nutrition as a prognostic indicator in amputations. A prospective study of 47 cases. Acta Orthop Scand. 1992;63(6):675–8.

    PubMed  CAS  Google Scholar 

  86. Isner JM, Pieczek A, Schainfeld R, et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet. 1996;348(9024):370–4.

    Article  PubMed  CAS  Google Scholar 

  87. Baumgartner I, Pieczek A, Manor O, et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation. 1998;97(12):1114–23.

    Article  PubMed  CAS  Google Scholar 

  88. Shintani S, Murohara T, Ikeda H, et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation. 2001;103(23):2776–9.

    Article  PubMed  CAS  Google Scholar 

  89. Kamihata H, Matsubara H, Nishiue T, et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation. 2001;104(9):1046–52.

    Article  PubMed  CAS  Google Scholar 

  90. Horsch S, Claeys L. Epidural spinal cord stimulation in the treatment of severe peripheral arterial occlusive disease. Ann Vasc Surg. 1994;8(5):468–74.

    Article  PubMed  CAS  Google Scholar 

  91. Klomp HM, Spincemaille GH, Steyerberg EW, Habbema JD, van Urk H. Spinal-cord stimulation in critical limb ischaemia: a randomised trial. ESES Study Group. Lancet. 1999;353(9158):1040–4.

    Article  PubMed  CAS  Google Scholar 

  92. Lundell A, Lindblad B, Bergqvist D, Hansen F. Femoropopliteal-crural graft patency is improved by an intensive surveillance program: a prospective randomized study. J Vasc Surg. 1995;21(1):26–33; discussion 33–4.

    Article  PubMed  CAS  Google Scholar 

  93. Illig KA, Surowiec S, Shortell CK, Davies MG, Rhodes JM, Green RM. Hemodynamics of distal revascularization-interval ligation. Ann Vasc Surg. 2005;19(2):199–207.

    Article  PubMed  Google Scholar 

  94. Ihlberg L, Luther M, Alback A, Kantonen I, Lepantalo M. Does a completely accomplished duplex-based surveillance prevent vein-graft failure? Eur J Vasc Endovasc Surg. 1999;18(5):395–400.

    Article  PubMed  CAS  Google Scholar 

  95. Ihlberg L, Luther M, Tierala E, Lepantalo M. The utility of duplex scanning in infrainguinal vein graft surveillance: results from a randomised controlled study. Eur J Vasc Endovasc Surg. 1998;16(1):19–27.

    Article  PubMed  CAS  Google Scholar 

  96. Arvela E, Dick F. Surveillance after distal revascularization for critical limb ischaemia. Scand J Surg. 2012;101(2):119–24.

    Article  PubMed  CAS  Google Scholar 

  97. Rollins KE, Coughlin PA. Functional outcomes following revascularisation for critical limb ischaemia. Eur J Vasc Endovasc Surg. 2012;43(4):420–5.

    Article  PubMed  CAS  Google Scholar 

  98. Crawford RS, Cambria RP, Abularrage CJ, et al. Preoperative functional status predicts perioperative outcomes after infrainguinal bypass surgery. J Vasc Surg. 2010;51(2):351–8; discussion 358–9.

    Article  PubMed  Google Scholar 

  99. Nguyen LL, Moneta GL, Conte MS, Bandyk DF, Clowes AW, Seely BL. Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia. J Vasc Surg. 2006;44(5):977–83; discussion 983–4.

    Article  PubMed  PubMed Central  Google Scholar 

  100. Conte MS, Bandyk DF, Clowes AW, et al. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg. 2006;43(4):742–51; discussion 751.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Vascular Surgery and Endovascular Therapy, Department of Surgery, Penn Presbyterian Medical Center, 51 North 39th Street, Wright-Saunders, Suite 266, Philadelphia, PA, 19104, USA

    Michael A. Golden MD

  2. Division of Vascular Surgery and Endovascular Therapy, Department of Surgery, University of Pennsylvania, Philadelphia, PA, USA

    Brant W. Ullery MD

Authors
  1. Michael A. Golden MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Brant W. Ullery MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael A. Golden MD .

Editor information

Editors and Affiliations

  1. Chief, Division of Vascular Surgery and Endovascular Services, and Lead Physician, Vascular Surgery Department of Veterans Affairs Healthcare, SUNY Upstate Medical University, and Network Upstate New York at Syracuse, Syracuse, New York, USA

    Vivian Gahtan

  2. Director of Endovascular Services, Division of Vascular Surgery and Endovascular Services, and Vascular Surgeon, Department of Veterans Affairs Healthcare, SUNY Upstate Medical University, and Network Upstate New York at Syracuse, Syracuse, New York, USA

    Michael J. Costanza

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Golden, M.A., Ullery, B.W. (2015). Critical Limb Ischemia. In: Gahtan, V., Costanza, M. (eds) Essentials of Vascular Surgery for the General Surgeon. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1326-8_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1326-8_7

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-1325-1

  • Online ISBN: 978-1-4939-1326-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation